Tags: cardiac arrhythmia monitoring | iRhythm Technologies | MyZio app | Novo A/S | Zio Patch |
iRhythm Technologies, maker of the Zio peel-and-stick wearable heart monitor, has launched a patient-facing companion app on iOS, called myZio, as well as a website, called myZio.com. The app and website allow wearers to track additional health data. They don’t display data collected by the Zio patch.
These are the first patient-facing data offerings that the company, which commercially launched Zio in 2011, has released. The wearable itself has no connectivity — it stores the data it collects locally on the device and is downloaded once the wearer mails the device back to the company.
“With the release of the myZIO app, iRhythm is strengthening its leadership among digital healthcare solution providers by enabling better insights to inform clinical decisions,” iRhythm Technologies CEO Kevin King said in a statement. “myZIO is one example of our commitment to putting our patients first. It is also a stepping stone to the creation of arrhythmia patient communities, giving our users a priceless source of education and support. By involving the patient in the clinical decision process, iRhythm is shaping the diagnostic pathway into a more collaborative one and, ultimately, one that dramatically improves patient outcomes.” Keep reading>>
Tags: Apple Watch | Argus Insights | Fitbit | heart rate tracking | Lumo | Lumo Lift | smartwatches | wearables |
In advance of the start of the holiday shopping season, Argus Insights has released a report on consumer perception and demand for wearables, based on the research firm’s analysis of 6,000 global reviews and social media conversations. As expected, Apple Watch tops the demand for consumer smartwatches, but surprisingly Fitbit didn’t top the dedicated fitness tracker category — it came in second after the Lumo Lift.
“The up and coming Lumo Lift Posture and Activity Tracker is winning over fitness tracker and band consumers with their instantly actionable posture-correcting device,” Argus writes in the report. “It is no surprise to see several Fitbit devices rounding out the top 10 devices, but the presence of a heart rate monitor is crucial in producing delight, placing the Charge HR and Jawbone Up4 with HR above the more oft reviewed basic Charge. While users are praising devices from Fitbit, Microsoft, Samsung, Garmin, Jawbone and Withings, devices from major players like Misfit and Xioami are failing to win over consumers.” Keep reading>>
Tags: Azumio | Azumio Argus | Health eHeart Study | National Institutes of Health | NIH | Stanford University |
Health app maker Azumio has partnered with Stanford University to make deidentified, anonymized data from a cohort of 5 million users available for research purposes. The study will be sponsored by a grant from the National Institutes of Health.
Azumio makes a number of different health tracking apps that track different biometrics including activity, heart rate, sleep, and diet, but the company has been working on integrating them all into one comprehensive tracking app called Argus. Stanford researchers will have data on users’ activity (including break-downs into walking, running, cycling, and working out), heart rate, diet (tracked in different ways including calories, food categories, and photographs of food), and sleep. They’ll be able to compare this data against demographic data, geographic data (50 percent of Azumio users are outside the United States), and data about how users share their Azumio data on social networks.
“The team that is working with Stanford on the data is coming from a different groups,” Azumio CEO Bojan Bostjancic told MobiHealthNews. “There are people interested in mobility, how people walk, gait, that sort of thing. There are people interested in diet and obesity. There are people who study social networks. It’s kind of heterogenous and everyone has their own agenda. There’s a lot of scientific curiosity, looking thorugh these datasets for the first time and trying to see the patterns in them.”
Tags: ClearCare | digital home care | home care | McKesson Ventures |
ClearCare has raised an undisclosed amount from McKesson Ventures for its cloud-based home care platform. The company has previously raised $15.5 million. ClearCare raised a seed round in November 2012.
Existing investors include Bessemer Venture Partners, Cambia Health Solutions, Voyager Capital, Qualcomm Ventures, and Harbor Pacific Capital. Keep reading>>
Tags: digital house call | Dispatch Health | house call |
Dispatch Health is adding an iOS app to its mobile house call service, which currently offers its service through local municipal services providers. For the first time with the new app, consumers will be able to request care from Dispatch Health directly, bringing the company more in-line with similar providers like Pager or Heal.
Denver, Colorado-based Dispatch Health maintains a fleet of cars staffed by acute care clinicians and equipped with a CLIA-certified lab, medical equipment, medications and IVs, and WiFi connectivity. When patients contact Dispatch Health, the company uses an algorithm to vet them and determine whether they can help. The startup focuses on treatable acute conditions including urinary tract infections, dehydration, minor fractures, asthma, constipation, nosebleeds, nausea, vomiting, or lacerations. The company accepts most local insurance, including Medicare and Medicaid, and will treat uninsured patients for a flat fee of $195.
While Dispatch Health has remained focused on its hometown of Denver, the company is casting a wide net in terms of how it makes its services available to Denverites. The company works with 911 dispatchers, with the local fire department, and with health systems and senior care facilities. In October, the company announced a partnership with Centura Health to help treat some of the health system’s patients. Keep reading>>
Tags: 3D anatomy modelling | FDA | FDA 510(k) | radiology | surgery | Visible Patient |
Visible Patient, a French company that makes 3D models of human organs to assist surgeons, has received FDA 510(k) clearance for its VP Planning Software Suite.
The software suite has had a CE Mark for six months and has been commercially available in Europe for a year. Via the software, surgeons send radiological data like CT and MRI scans to Visible Patient. In-house designers create 3D models based on that data, and surgeons can then use that data to plan the surgery and as a visual aide to communicate with patients.
“[FDA clearance] represents a key step in our development,” Erick Cloix, president of Visible Patient, said in a statement. “We are eager to offer American surgeons this technology that many surgeons in Europe have already adopted.”
In Europe, the suite also includes an iOS and Android app on which surgeons can display the models and show them to patients. The app has not yet been cleared by the FDA, and therefore won’t be coming to the US market, at least at first. Keep reading>>